GD2 ganglioside-binding antibody and specific aurora A kinase inhibitor induce autophagy in 1MR-32 neuroblastoma cells

被引：0
|
作者：
Durbas, Malgorzata [1 ]
Pabisz, Pawel [2 ]
Wawak, Katarzyna [2 ]
Boratyn, Elzbieta [1 ]
Nowak, Iwona [1 ]
Horwacik, Irena [1 ]
Rokita, Hanna [1 ]
机构：
[1] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Lab Mol Genet & Virol, Gronostajowa 7, PL-30387 Krakow, Poland
[2] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Gronostajowa 7, PL-30387 Krakow, Poland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
122
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 13 条
  • [1] GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells
    Małgorzata Durbas
    Paweł Pabisz
    Katarzyna Wawak
    Aneta Wiśniewska
    Elżbieta Boratyn
    Iwona Nowak
    Irena Horwacik
    Olga Woźnicka
    Hanna Rokita
    Apoptosis, 2018, 23 : 492 - 511
  • [2] GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells
    Durbas, Magorzata
    Pabisz, Pawe
    Wawak, Katarzyna
    Wisniewska, Aneta
    Boratyn, Elzbieta
    Nowak, Iwona
    Horwacik, Irena
    Woznicka, Olga
    Rokita, Hanna
    APOPTOSIS, 2018, 23 (9-10) : 492 - 511
  • [3] Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
    Horwacik, Irena
    Durbas, Malgorzata
    Boratyn, Elzbieta
    Wegrzyn, Paulina
    Rokita, Hanna
    CANCER LETTERS, 2013, 341 (02) : 248 - 264
  • [4] Analysis of genes involved in response to doxorubicin and a GD2 ganglioside-specific 14G2a monoclonal antibody in IMR-32 human neuroblastoma cells
    Horwacik, Irena
    Durbas, Malgorzata
    Boratyn, Elzbieta
    Sawicka, Anna
    Wegrzyn, Paulina
    Krzanik, Sylwia
    Gorka, Anna
    Drozniak, Joanna
    Augustyniak, Ewa
    Kowalczyk, Aleksandra
    Rokita, Hanna
    ACTA BIOCHIMICA POLONICA, 2015, 62 (03) : 423 - 433
  • [5] Binding activities and antitumor properties of a new Mouse/Human chimeric antibody specific for GD2 ganglioside antigen
    Alvarez-Rueda, Nidia
    Leprieur, Stephanie
    Clemenceau, Beatrice
    Supiot, Stephane
    Sebille-Rivain, Veronique
    Faivre-Chauvet, Alain
    Davodeau, Francois
    Paris, Francois
    Barbet, Jacques
    Aubry, Jacques
    Birkle, Stephane
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5613S - 5620S
  • [6] Apoptosis is responsible for the cytotoxic effects of anti-GD2 ganglioside antibodies and aurora A kinase inhibitors on human neuroblastoma cells
    Durbas, Malgorzata
    Rokita, Hanna
    Horwacik, Irena
    Wisniewska, Aneta
    Nowak, Iwona
    ACTA BIOCHIMICA POLONICA, 2022, : 485 - 494
  • [7] Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells
    Zhu, Weihong
    Mao, Xinzhan
    Wang, Wanchun
    Chen, You
    Li, Ding
    Li, Hui
    Dou, Pengcheng
    PHARMAZIE, 2018, 73 (02): : 80 - 86
  • [8] GANGLIOSIDE GD2 SPECIFIC MONOCLONAL ANTIBODY-3F8 - A PHASE-I STUDY IN PATIENTS WITH NEUROBLASTOMA AND MALIGNANT-MELANOMA
    CHEUNG, NKV
    LAZARUS, H
    MIRALDI, FD
    ABRAMOWSKY, CR
    KALLICK, S
    SAARINEN, UM
    SPITZER, T
    STRANDJORD, SE
    COCCIA, PF
    BERGER, NA
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1430 - 1440
  • [9] GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines
    Durbas, Malgorzata
    Horwacik, Irena
    Boratyn, Elzbieta
    Kamycka, Elzbieta
    Rokita, Hanna
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 1143 - 1159
  • [10] MURINE MONOCLONAL-ANTIBODY (MAB) SPECIFIC FOR GD2 GANGLIOSIDE - A PHASE-I TRIAL IN PATIENTS WITH NEUROBLASTOMA, MELANOMA AND OSTEOGENIC-SARCOMA
    CHEUNG, NK
    BERGER, N
    COCCIA, P
    KALLICK, S
    LAZARUS, H
    MIRALDI, F
    SAARINEN, U
    STRANDJORD, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 318 - 318
12